Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia.

A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia. Abstract Text:

    takami tomiyamaTakami Tomiyama,tetsu nagataTetsu Nagata,hiroyuki shimadaHiroyuki Shimada,rie teraokaRie Teraoka,akiko fukushimaAkiko Fukushima,hyoue kanemitsuHyoue Kanemitsu,hiroshi takumaHiroshi Takuma,ryozo kuwanoRyozo Kuwano,masaki imagawaMasaki Imagawa,suzuka atakaSuzuka Ataka,yasuhiro wadaYasuhiro Wada,eito yoshiokaEito Yoshioka,tomoyuki nishizakiTomoyuki Nishizaki,yasuyoshi watanabeYasuyoshi Watanabe,hiroshi moriHiroshi Mori,

    OBJECTIVE: Soluble oligomers of amyloid beta (Abeta), rather than amyloid fibrils, have been proposed to initiate synaptic and cognitive dysfunction in Alzheimer's disease (AD). However, there is no direct evidence in humans that this mechanism can cause AD. Here, we report a novel amyloid precursor protein (APP) mutation that may provide evidence to address this question. METHODS: A Japanese pedigree showing Alzheimer's-type dementia was examined for mutations in APP, PSEN1, and PSEN2. In addition, 5,310 Japanese people, including 2,121 patients with AD, were screened for the novel APP mutation. The pathogenic effects of this mutation on Abeta production, degradation, aggregation, and synaptotoxicity were also investigated. RESULTS: We identified a novel APP mutation (E693Delta) producing variant Abeta lacking gulutamate-22 (E22Delta) in Japanese pedigrees showing Alzheimer's-type dementia and AD. Although the secretion of total Abeta was markedly reduced by this mutation, the variant Abeta was more resistant to proteolytic degradation. The mutant peptides showed the unique aggregation property of enhanced oligomerization but no fibrillization, and inhibited hippocampal long-term potentiation more potently than wild-type peptide in rats in vivo. Consistent with the nonfibrillogenic property of the variant Abeta, a very low amyloid signal was observed in the patient's brain on positron emission tomography using Pittsburgh compound-B. INTERPRETATION: The E693Delta mutation has been suggested as a cause of dementia because of enhanced formation of synaptotoxic Abeta oligomers. Our findings may provide genetic validation in humans for the emerging hypothesis that the synaptic and cognitive impairment in AD is primarily caused by soluble Abeta oligomers.

    A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia. Publishing Authors By Initials

    t tomiyamaT Tomiyama,t nagataT Nagata,h shimadaH Shimada,r teraokaR Teraoka,a fukushimaA Fukushima,h kanemitsuH Kanemitsu,h takumaH Takuma,r kuwanoR Kuwano,m imagawaM Imagawa,s atakaS Ataka,y wadaY Wada,e yoshiokaE Yoshioka,t nishizakiT Nishizaki,y watanabeY Watanabe,h moriH Mori,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Annals of neurology

    VOLUME: 63

    Page Numbers: 377-87

    Journal Abbreviation:

    ISSN: 1531-8249

    DAY: 3

    MONTH: Mar

    YEAR: 2008

    A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7707449

    A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia.

    AFFILIATION: Department of Neuroscience, Osaka City University Graduate School of Medicine, Osaka, Japan.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Ann Neurol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News